Box score
GlycosBio Inc.
Reported $1.1M sold in a new Form D filed March 21, 2024 (Houston, Texas).
- Biggest raise
- $1.1M filed Mar 21, 2024
- League
- Bio & Health Biotechnology
- Based in
- Houston, Texas
- Season rank
- #893 of 1,389 in the Bio & Health League; #6719 of 12,443 overall (2024)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2024-03-21 | New notice | $1.1M | $5M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1427515.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Bio-path Holdings, Inc. | Bio & Health | $1.3M |
| 2 | North Texas Renal Management, LLC | Bio & Health | $1.2M |
| 3 | C4 Imaging, LLC | Bio & Health | $1M |
| 4 | 7 Hills Pharma Inc. rookie | Bio & Health | $1M |
| 5 | Cessation Therapeutics, Inc. | Bio & Health | $1M |
| 6 | Memgen, Inc. | Bio & Health | $950K |